Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1695758

registered interest
date	13/03/2024
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Advanced Therapy Medicinal Products: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to help support research into cell and gene therapy in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	18416
answer	answer is ministerial correction date of answer 22/03/2024 answer text <p>The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult (CGTC).</p><p> </p><p>DSIT also invested £10 million - alongside £10 million from Scottish Enterprise – to support a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Glasgow.</p><p> </p><p>The Vaccine Taskforce provided funding for a state-of-the art CGTC facility in Braintree to accelerate the development and manufacturing of advanced therapies at clinical and commercial scale.</p><p> </p><p>My department also supported CGTC to establish apprenticeships and training programmes to upskill people across the UK.</p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 22/03/2024 09:30:33 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1695759

registered interest
date	13/03/2024
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Advanced Therapy Medicinal Products: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to increase Scotland’s (a) manufacturing capacity for and (b) delivery of cell and gene therapies.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	18417
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The government is investing significantly to support manufacturing and delivery of cell and gene therapies.</p><p /><p>Since 2021, government has launched three UK-wide capital grant schemes – up to £118 million of funds – to incentivise manufacturing investments, including in advanced therapies. Last year, government announced a further £520 million to increase investment in Life Sciences manufacturing.</p><p> </p><p>The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult which also coordinates the Advanced Therapy Treatment Centre network.</p><p> </p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 21/03/2024 09:26:38 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1652105

registered interest
date	11/07/2023
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Trade Marks: Registration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, if he will make an assessment of the effectiveness of the Financial Conduct Authority's procedures for ensuring that all trading names associated with a single registration are properly authorised.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	193391
answer	answer is ministerial correction date of answer 18/07/2023 answer text <p>The Financial Conduct Authority (FCA) is an operationally independent non-governmental body responsible for regulating and supervising the financial services industry. Although the Treasury sets the legal framework for the regulation of financial services, the FCA is responsible for developing and implementing rules, including relating to trading names. Further information on the FCA’s approach is available on its website.</p><p> </p><p>Through the Financial Services Act 2021, the government granted the FCA new powers to remove permissions from firms when they are not carrying out the regulated activities they are permitted to. The FCA has since undertaken a ‘use it or lose it’ exercise, removing firms’ permissions where they are not carrying out regulated activities.</p><p> </p><p>This has seen the FCA carry out 1,090 assessments in 2021/22 and resulted in 264 firms applying to voluntarily cancel, and a further 47 to modify, their permission to carry out regulated activities.</p><p> </p><p>Ministers regularly engage with the FCA on a range of issues while recognising that the independence of the FCA is critical to its functions.</p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 18/07/2023 08:13:37 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1652106

registered interest
date	11/07/2023
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Trade Marks: Registration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, if he will make an assessment of the effectiveness of the Financial Conduct Authority's procedures for authorising the association of multiple trading names with a single registration.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	193392
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p>The Financial Conduct Authority (FCA) is an operationally independent non-governmental body responsible for regulating and supervising the financial services industry. Although the Treasury sets the legal framework for the regulation of financial services, the FCA is responsible for developing and implementing rules, including relating to trading names. Further information on the FCA’s approach is available on its website.</p><p> </p><p>Through the Financial Services Act 2021, the government granted the FCA new powers to remove permissions from firms when they are not carrying out the regulated activities they are permitted to. The FCA has since undertaken a ‘use it or lose it’ exercise, removing firms’ permissions where they are not carrying out regulated activities.</p><p> </p><p>This has seen the FCA carry out 1,090 assessments in 2021/22 and resulted in 264 firms applying to voluntarily cancel, and a further 47 to modify, their permission to carry out regulated activities.</p><p> </p><p>Ministers regularly engage with the FCA on a range of issues while recognising that the independence of the FCA is critical to its functions.</p><p> </p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 19/07/2023 07:34:15 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray